Resibufogenin
| CAS No. | 465-39-4 | Cat. No. | BCP20705 |
| Name | Resibufogenin | ||
| Synonyms | RBG; Bufotenine; | ||
| Formula | C24H32O4 | M. Wt | 384.51 |
| Description | Resibufogenin is a cardiac glycoside first isolated from Bufonis venom that acts as an inhibitor of the Na+/K+-ATPase.It exhibits cardiotonic, vasopressor, and respiratory stimulating actions in both animal and clinical models.Resibufogenin has been used to antagonize the action of marinobufagenin in a rat experimental model of preeclampsia. Resibufogenin is also reported to have antiproliferative effects against cancer cells, inducing cell cycle arrest by suppressing the expression of cyclin D1. | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.